EXPERIENCE ON THE USE OF TERIPARATIDE FOR TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS

被引：0

|

作者：

Saparbayeva, M. ^{[1
]}

Issayeva, B. ^{[1
]}

Issayeva, S. ^{[1
]}

机构：

[1] Asfendiyarov Kazakh Natl Med Univ, Alma Ata, Kazakhstan

来源：

OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P713

引用

收藏

页码：S377 / S378

页数：2

相关论文

共 50 条

[21] Prophylaxis and Treatment of Glucocorticoid-induced Osteoporosis
Oelzner, Peter
Wolf, Gunter
AKTUELLE RHEUMATOLOGIE, 2017, 42 (03) : 233 - 244
[22] Prevention and treatment of glucocorticoid-induced osteoporosis
Lane, NF
Lukert, B
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1999, 5 (05) : S16 - S22
[23] PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
LIBANATI, C
CHEST, 1993, 104 (06) : 1936 - 1936
[24] Pathogenesis and Treatment of Glucocorticoid-Induced Osteoporosis
Paula J. Rackoff
Clifford J. Rosen
Drugs & Aging, 1998, 12 : 477 - 484
[25] Glucocorticoid-induced osteoporosis: Prevention and treatment
Werth, VP
REVUE DU RHUMATISME, 1997, 64 (06): : S84 - S88
[26] Denosumab in the treatment of glucocorticoid-induced osteoporosis
Ilke Coskun Benlidayi
Rheumatology International, 2018, 38 : 1975 - 1984
[27] Glucocorticoid-induced osteoporosis -: Assessment and treatment
Reid, IR
JOURNAL OF CLINICAL DENSITOMETRY, 1998, 1 (01) : 65 - 73
[28] Advances in treatment of glucocorticoid-induced osteoporosis
Hsu, Emory
Nanes, Mark
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (06) : 411 - 417
[29] Treatment options for glucocorticoid-induced osteoporosis
Chiodini, Iacopo
Merlotti, Daniela
Falchetti, Alberto
Gennari, Luigi
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (06) : 721 - 732
[30] Denosumab in the treatment of glucocorticoid-induced osteoporosis
Benlidayi, Ilke Coskun
RHEUMATOLOGY INTERNATIONAL, 2018, 38 (11) : 1975 - 1984

← 1 2 3 4 5 →